Evidence map›Paper›PMID 41995392›Full record

ArticleJournal of extracellular vesicles2026

Yersinia enterocolitica O:3 Outer Membrane Vesicles as a Platform for Complement Activation.

Cédric Battaglino, Iryna Bodnaruk, Paula Czyszczoń, Mikael Skurnik, Beata Filip-Psurska, Dariusz Jarych, Anna Maciejewska, Mariusz Gadzinowski, Kamil Malik, Izabela Potocka and 6 more

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Cédric BattaglinoInstitute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.
Iryna BodnarukInstitute of Biology, Biotechnology and Environmental Protection Faculty of Natural Sciences, University of Silesia, Katowice, Poland.
Paula CzyszczońLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Mikael SkurnikDepartment of Bacteriology and Immunology, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Beata Filip-PsurskaLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Dariusz JarychInstitute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.
Anna MaciejewskaLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Mariusz GadzinowskiCenter of Molecular and Macromolecular Studies, Polish Academy of Sciences, Lodz, Poland.
Kamil MalikInstitute of Biology, Biotechnology and Environmental Protection Faculty of Natural Sciences, University of Silesia, Katowice, Poland.
Izabela PotockaInstitute of Biology, Biotechnology and Environmental Protection Faculty of Natural Sciences, University of Silesia, Katowice, Poland.
Paweł MigdałLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Roksana KruszakinLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Maciej CedzyńskiInstitute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.
Katarzyna KasperkiewiczInstitute of Biology, Biotechnology and Environmental Protection Faculty of Natural Sciences, University of Silesia, Katowice, Poland.
Jolanta LukasiewiczLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Anna S ŚwierzkoInstitute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.ORCID https://orcid.org/0000-0001-9829-864X

Funding

Narodowe Centrum Nauki 2018/31/B/NZ6/03514National Science Centre, Poland
6 · The paper itself

Abstract

Lipopolysaccharide (LPS) is the major component of the outer membrane vesicles (OMVs) of Gram-negative bacteria. We hypothesized that OMVs-induced complement activation contributes to the development of systemic inflammatory response syndrome (SIRS). Yersinia enterocolitica O:3 (YeO3) variants synthesizing LPS of various chemotypes (S, Ra, Rd1, Re) were used as model microorganisms. OMVs activated complement more potently than parental bacteria or homologous LPS, independently of chemotype. A high molecular weight polysaccharide fraction, distinct from LPS, was recognized by serum mannose-binding lectin (MBL). In vivo experiments demonstrated that complement depletion weakened the hallmarks of OMVs-induced SIRS in mice. LPS chemotype affected the biodistribution of OMVs and long O-specific polysaccharide protected them from clearance. Chemotype influenced OMVs secretion with their highest release by bacteria with LPS reduced to the inner core and lipid A (Rd1). The shift from environmental to host's temperature stimulated secretion of smaller OMVs, with less-toxic, tetra-acyl lipid A. Our data are consistent with a contribution of OMVs to Yersinia pathogenicity through complement activation. Their potency as complex virulence factor is influenced by size, length of oligo-/polysaccharide chain, and lipid A form. This study comprehensively characterizes OMV-complement interactions in YeO3, extending the knowledge of mechanisms previously established for other Gram-negative bacteria.

Indexed as

Bacterial Outer MembraneComplement ActivationExtracellular VesiclesYersinia enterocoliticaAnimalsLipopolysaccharidesMannose-Binding LectinMiceSystemic Inflammatory Response SyndromeYersinia InfectionsLipopolysaccharidesMannose-Binding Lectinbiodistributioncomplementlipopolysaccharide (LPS)mannose‐binding lectin (MBL)outer membrane vesicles (OMVs)systemic inflammatory response syndrome (SIRS)Yersinia

Identifiers

PMID41995392
PMCPMC13088890

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.